Department of Cardiovascular Medicine, The Cardiovascular Institute, 3-2-19 Nishiazabu, Minato-Ku, Tokyo, 106-0031, Japan.
Department of Cardiovascular Surgery, The Cardiovascular Institute, Tokyo, Japan.
Heart Vessels. 2021 Dec;36(12):1861-1869. doi: 10.1007/s00380-021-01879-y. Epub 2021 Jun 4.
The incidence of ischemic stroke (IS) increases in patients with enlarged left atrium (LA) irrespective of whether or not the existence of atrial fibrillation (AF). In such situation, it is unclear whether the impact of LA on incidence of IS still significant in young, non-AF patients with enlarged LA who are primarily unconcerned on anticoagulation therapy. The study population consisted of 18,511 consecutive patients not receiving oral anticoagulants and undergoing echocardiography with measurement of LAD at baseline. The incidence rate of ischemic stroke was calculated in 3 groups according to left atrial dimension (LAD; < 30, 30-45 and ≥ 45 mm) in AF and non-AF patients. Further subgroup analysis was performed in stratification by elderly and young (aged ≥ 65 and < 65 years, respectively). The incidences of IS (per 100 patient-years) were 0.11 and 0.71 in non-AF and AF patients with LAD < 30 mm, respectively, which increased to 0.58 and 1.35 in LAD ≥ 45 mm (adjusted hazard ratios [HRs]; 1.95 [95% confidence intervals, CIs: 0.76-5.01] and 1.22 [95% CIs: 0.27-5.58], interaction P was 0.246). In non-AF patients, the incidences of IS were 0.30 and 0.04 in elderly and young patients with LAD < 30 mm, which increased to 0.67 and 0.48 in LAD ≥ 45 mm (adjusted HRs; 1.34 [95% CIs: 0.43-4.15] and 4.21 [95% CIs: 0.77-23.12], interaction P was 0.158). The incidence of IS significantly increased with increase of LAD in non-AF, especially in non-AF and young patients, although the difference was not independent of other clinical factors. The impact of LAD on IS was numerically larger in non-AF than in AF, and larger in young and non-AF than in elderly counterpart, although a significant interaction was not observed in this small population. Further studies with large population are necessary to judge whether these population with enlarged LA need antithrombotic therapy.
左心房(LA)增大的患者不论是否存在心房颤动(AF),其缺血性卒中(IS)的发生率均会增加。在这种情况下,对于主要不考虑抗凝治疗的、LA 增大的年轻非 AF 患者,LA 对 IS 发生率的影响是否仍然显著,尚不清楚。该研究人群包括 18511 例连续未接受口服抗凝治疗且基线时行超声心动图测量左房内径(LAD)的患者。根据 AF 和非 AF 患者的左心房大小(LAD; < 30、30-45 和 ≥ 45 mm),计算 IS 的发生率。进一步按老年(年龄 ≥ 65 岁)和年轻(年龄 < 65 岁)进行亚组分析。非 AF 和 AF 患者中 LAD < 30 mm 的 IS 发生率(每 100 患者年)分别为 0.11 和 0.71,而 LAD ≥ 45 mm 的 IS 发生率分别增至 0.58 和 1.35(校正后的风险比 [HR];1.95 [95%置信区间,95%CI:0.76-5.01] 和 1.22 [95%CI:0.27-5.58],交互 P 值为 0.246)。在非 AF 患者中,LAD < 30 mm 的老年和年轻患者的 IS 发生率分别为 0.30 和 0.04,而 LAD ≥ 45 mm 的 IS 发生率分别增至 0.67 和 0.48(校正后的 HR;1.34 [95%CI:0.43-4.15] 和 4.21 [95%CI:0.77-23.12],交互 P 值为 0.158)。尽管差异不受其他临床因素的影响,但在非 AF 患者中,随着 LAD 的增加,IS 的发生率显著增加,尤其是在非 AF 和年轻患者中。在这个小人群中,未观察到显著的交互作用,但 LA 大小对 IS 的影响在非 AF 中数值上大于 AF,在年轻和非 AF 中大于老年,尽管如此。仍需要进行更大规模的人群研究,以判断 LA 增大的这些人群是否需要抗血栓治疗。